BOSTON (AP) _ Flex Pharma Inc. (FLKS) on Monday reported a loss of $2.6 million in its third quarter.
The Boston-based company said it had a loss of 15 cents per share.
The biotech drug developer posted revenue of $251,000 in the period.
The company's shares closed at 63 cents. A year ago, they were trading at $3.32.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FLKS at https://www.zacks.com/ap/FLKS